• 3660 Citations
  • 31 h-Index
19932011
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Nicolo' Gebbia is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 28 Similar Profiles
gemcitabine Medicine & Life Sciences
zoledronic acid Medicine & Life Sciences
Mutation Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Research Output 1993 2011

EGFR genomic alterations in cancer: prognostic and predictive values

Terrasi, M., Russo, A., Di Gaudio, F., Bronte, G., Gebbia, N., Gulotta, G., Siragusa, S., Cajozzo, M., Sivestris, N., Siragusa, S., Ficorella, C. & Rizzo, S., 2011, In : Default journal. 3, p. 879-887 9 p.

Research output: Contribution to journalArticle

erbB-1 Genes
Genes
Gene Dosage
Glioma
Antineoplastic Agents

Management and treatment of triple-negative breast cancer patients from the NEMESI study: An Italian experience.

Gebbia, N., Conte, Ricciardi, G. R. R., Venturini, Dondi, Giuffrida, D., Adamo, V., Colucci, Cognetti, F., De Placido & Masci, 2011, In : Default journal. x, 6 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Therapeutics
Adjuvant Chemotherapy
Neoplasms
Breast Neoplasms

Anti-endothelin drugs in solid tumors

Russo, A., Bazan, V., Fanale, D., Bronte, G., Gebbia, N., Di Gaudio, F. & Rizzo, S., 2010, In : Default journal. 15, p. 27-40 14 p.

Research output: Contribution to journalArticle

Endothelins
Prostatic Neoplasms
Castration
Pharmaceutical Preparations
Endothelin A Receptors

Bortezomib: a new pro-apoptotic agent in cancer treatment.

Cicero, G., Bronte, G., Russo, A., Gebbia, N., Fulfaro, F., Adamo, V. & Rizzo, S., 2010, In : Default journal. 10(1), p. 55-67 13 p.

Research output: Contribution to journalArticle

Neoplasms
Therapeutics
Dexamethasone
Pharmaceutical Preparations
Biological Phenomena

Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma

Gebbia, N., Bronte, G., Bazan, V., Russo, A., La Paglia, L., Siragusa, S., Siragusa, S., Ficorella, C., Adamo, V., Colucci, G., Santini, D. & Rizzo, S., 2010, In : Default journal. 36 (3), p. 21-29 9 p.

Research output: Contribution to journalArticle

Mutation
Epidermal Growth Factor Receptor
erbB-1 Genes
Therapeutics
Gene Fusion